--2025/Q3-- / 8.604M--
--2025/Q2-- / 5.736M--
--2025/Q10.000 / 0.000--
--2024/Q40.000 / 0.000--
--------
Tesla
TSLA
Adobe
ADBE
Ecopetrol
EC
Petroleo Brasileiro SA Petrobras
PBR
Strategy
MSTR
US Stock MarketDetailed Quotes
CTOR Citius Oncology
- 0.794
- +0.084+11.83%
Close Mar 25 16:00 ET
- 0.818
- +0.024+2.98%
Post 19:47 ET
56.81MMarket Cap-2.46P/E (TTM)
0.980High0.710Low460.86KVolume0.780Open0.710Pre Close381.17KTurnover8.38%Turnover RatioLossP/E (Static)71.55MShares49.00052wk High1.38P/B4.37MFloat Cap0.55152wk Low--Dividend TTM5.50MShs Float49.000Historical High--Div YieldTTM38.01%Amplitude0.551Historical Low0.827Avg Price1Lot Size
Citius Oncology Key Stats
Citius Oncology Earnings Estimates
Revenue
EPS
EBIT
Revenue is based on 1 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement
Currency: USD
Actual
Estimate
Unlock Free Earnings Estimates
Open Account
Citius Oncology Earnings Reports
Read more
Market Insights
Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries
Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.
Analysis
Price Target
No Data
